Literature DB >> 20075386

Fibrin resistance to lysis in patients with pulmonary hypertension other than thromboembolic.

Massimo Miniati1, Claudia Fiorillo, Matteo Becatti, Simonetta Monti, Matteo Bottai, Carlo Marini, Elisa Grifoni, Bruno Formichi, Carolina Bauleo, Chiara Arcangeli, Daniela Poli, Paolo Antonio Nassi, Rosanna Abbate, Domenico Prisco.   

Abstract

RATIONALE: Reportedly, fibrin isolated from patients with chronic thromboembolic pulmonary hypertension (CTEPH) is resistant to lysis. Persistence of regions within the fibrin beta chain, which mediate cell signaling and migration, could trigger the organization of pulmonary thromboemboli into chronic intravascular scars.
OBJECTIVES: Ascertain whether fibrin resistance to lysis occurs in patients with pulmonary hypertension (PAH) other than CTEPH, and in those with prior pulmonary embolism (PE) and no pulmonary hypertension.
METHODS: Fibrinogen was purified from 96 subjects (17 with CTEPH, 14 with PAH, 39 with prior PE, and 26 healthy control subjects) and exposed to thrombin to obtain fibrin clots. Plasmin-mediated cleavage of fibrin beta chain was assessed hourly over a 6-hour period by polyacrylamide gel electrophoresis. Fibrin band intensity was measured by densitometry of stained gels. Data were normalized to the band intensity of the undigested protein.
MEASUREMENTS AND MAIN RESULTS: By 1 hour of digestion, fibrin band intensity had decreased by a median of 25% (interquartile range [IQR], 20 to 27%) in control subjects, and by 15% (IQR, 11 to 18%) in patients with prior PE (P < 0.0001). The 1-hour median reduction in band intensity was 2% (IQR, 1 to 3%) in CTEPH, and 4% (IQR, 2 to 7%) in PAH (P < 0.0001 vs. control subjects and PE). The decline in fibrin band intensity remained significantly different among the four groups up to 6 hours (P < 0.0001).
CONCLUSIONS: Fibrin resistance to lysis occurs in pulmonary hypertension other than CTEPH and, to a smaller extent, in patients with prior PE and no pulmonary hypertension.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20075386     DOI: 10.1164/rccm.200907-1135OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  18 in total

1.  Hazelnut-enriched chocolate improves flow-mediated artery dilatation via inhibition of oxidative stress.

Authors:  Matteo Becatti; Claudia Fiorillo
Journal:  Intern Emerg Med       Date:  2018-09-08       Impact factor: 3.397

2.  Oxidative stress management during non-invasive ventilation in acute respiratory failure.

Authors:  Matteo Becatti; Niccolò Taddei; Claudia Fiorillo
Journal:  Intern Emerg Med       Date:  2017-12-21       Impact factor: 3.397

Review 3.  The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus.

Authors:  Ozan Ünlü; Stephane Zuily; Doruk Erkan
Journal:  Eur J Rheumatol       Date:  2015-12-29

Review 4.  Vascular Manifestations in Antiphospholipid Syndrome (APS): Is APS a Thrombophilia or a Vasculopathy?

Authors:  Salma Siddique; Jessie Risse; Guillaume Canaud; Stéphane Zuily
Journal:  Curr Rheumatol Rep       Date:  2017-09-04       Impact factor: 4.592

Review 5.  Pulmonary hypertension in antiphospholipid syndrome.

Authors:  Stéphane Zuily; Denis Wahl
Journal:  Curr Rheumatol Rep       Date:  2015-01       Impact factor: 4.592

Review 6.  Nets, pulmonary arterial hypertension, and thrombo-inflammation.

Authors:  Luís Pedro Baptista de Barros Ribeiro Dourado; Mário Santos; Daniel Moreira-Gonçalves
Journal:  J Mol Med (Berl)       Date:  2022-04-20       Impact factor: 4.599

7.  Hyperhomocysteinemia in patients with pulmonary embolism is associated with impaired plasma fibrinolytic capacity.

Authors:  Anna Paola Cellai; Donatella Lami; Emilia Antonucci; Agatina Alessandrello Liotta; Angela Rogolino; Sandra Fedi; Claudia Fiorillo; Matteo Becatti; Caterina Cenci; Rossella Marcucci; Rosanna Abbate; Domenico Prisco
Journal:  J Thromb Thrombolysis       Date:  2014-07       Impact factor: 2.300

Review 8.  Thrombosis, platelets, microparticles and PAH: more than a clot.

Authors:  Katie L Lannan; Richard P Phipps; R James White
Journal:  Drug Discov Today       Date:  2014-04-18       Impact factor: 7.851

Review 9.  Coagulation and the vessel wall in pulmonary embolism.

Authors:  Sherin Alias; Irene M Lang
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

Review 10.  Current concepts in the pathogenesis of chronic thromboembolic pulmonary hypertension.

Authors:  Daniel T Matthews; Anna R Hemnes
Journal:  Pulm Circ       Date:  2016-06       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.